HOPA Practice Management Course 2019

HOPA Practice Management Session Descriptions

Registration Information


Friday, September 13, 2019

8–11 am

Preconference Options (.03 CEU)

*Available at an additional cost

UAN 0465-0000-19-078-L04-P Available as live and virtual add-on

Option 1: Investigational Drug Services: Safety, Standards, and Regulatory

Medication Safety

The session will provide an overview of the safety issues associated with clinical trials. The presentation will focus primarily on the issue of clinical trial medication labeling and the associated medication safety risk.

Richard Needleman, RpH

What's Out There, Where Is It Going

The session will discuss the changes in IDS over the last several years, some best practice recommendations, will touch upon future direction and some initiatives underway in the IDS setting.

Sapna Amin, PharmD BCOP

How to Have Successful Audits

This session will discuss experience gained through having many research pharmacy audits.

Caroline Harvey, RpH MS

UAN 0465-0000-19-079-L04-P On-site visit (live only)

Option 2: Walgreens

More information coming soon.

UAN 0465-0000-19-080-L04-P On-site visit (live only)

Option 3: Zero to Sixty at Lightning Speed: Growing a Comprehensive Oncology Pharmacy Team

Atrium Health (formerly Carolinas HealthCare System) includes more than 40 hospitals and 900 care locations ranging from doctors’ offices to behavioral health centers to nursing homes. At Atrium Health’s Levine Cancer Institute (LCI), our vision is to redefine the role of a traditional cancer center by bringing cancer research and clinical innovations closer to patients. With over 25 cancer locations throughout the Carolinas, patients have access to world-class care close to home.

Since 2014, our Charlotte Metro LCI Oncology Pharmacy team has experienced extensive growth. We have expanded our pharmacy coverage from 3 to 19 different LCI locations resulting in over a 200% increase in infusion chair coverage. Over the last 5 years, we have designed and built over 16 LCI infusion pharmacies and have added over 80 new pharmacy positions, including a PGY2 Oncology residency program to our LCI pharmacy team.  In addition to infusion coverage, we have expanded our pharmacy presence in multiple clinics across the LCI enterprise while implementing various pharmacy driven protocols and initiatives.  Attendees will have the opportunity to learn how we have justified, grown and developed our comprehensive LCI Oncology Pharmacy service line, followed by a tour of our largest LCI facility to meet some of our pharmacy teammates and see initiatives in action.

At the end of this visit, attendees will be able to:

  • Discuss how to navigate pharmacy design and construction projects at over 16 infusion pharmacies including the need to meet USP 800 standards and tour LCI’s newest infusion pharmacy.
  • Describe the strategies LCI Pharmacy used to justify and hire pharmacy positions to meet the growing demands and expand our infusion and clinical service line across the enterprise.
  • Identify initiatives implemented to improve efficiency, provide cost savings, improve quality without increasing costs and transition of work to allow teammates the ability to work at the top of their license.
  • Discuss how LCI Pharmacy created instrumental service line extensions such as: our Patient Assistance Program run by LCI pharmacy technicians and our partnership with our Atrium Health Specialty Pharmacy team and Investigational Drug Services Pharmacy team.
  • Review LCIs use of emerging clean room admixing technologies by implementing gravimetric and volumetric technology in our clean rooms across the LCI pharmacy enterprise. Attendees will be able to see the technology in use during their tour.

12–1 pm

General Session (0.1 CEU)

UAN 0465-0000-19-094-L04-P Included in virtual meeting

Biosimilar Flipped Classroom

  • Pre-work
    • Describe approval process for biosimilars
    • Identify current opportunities in the market
  • Payor:
    • Discuss pros and cons for preferring a biosimilar
    • Describe the process for reaching a formulary decision (rebates, enforcement)
  • Provider:
    • Discuss pros and cons for preferring a biosimilar
    • Describe the process for reaching a formulary decision (GPO rebates, reimbursement incentives)

Laura Asakura, PharmD BCOP BCPS

David Chen, PharmD

Estay Greene, PharmD MBA

1–2 pm

General Session (0.1 CEU)

UAN 0465-0000-19-081-L04-P Included in virtual meeting

Integrative Oncology - Separating Wheat from Chaff

By the end of this session attendees will be able to:

  • Distinguish between complementary, alternative, and integrative medicine.
  • Understand the importance of offering evidence-based integrative care to people with cancer.
  • Discuss research findings associated with the use of select complementary therapies, including supplements and herbs.
  • Identify complementary medical interventions that could benefit patients in specific clinical circumstances.
  • Explore the pharmacist's active role in the Integrative Oncology Clinic of the future.

Russell Greenfield, MD

2:10–3:10 pm

General Session (0.1 CEU)

UAN 0465-0000-19-082-L04-P Included in virtual meeting

Precision Medicine Integration into Practice

This session will review the overall landscape of precision medicine and pertinent areas of application within pharmacy. Evidence supporting key elements of pharmacy-led precision medicine program implementation will be evaluated. Considerations with regard to the use of the electronic medical record as a tool to support precision medicine education and ordering practices will be assessed. Lastly, a summary of the vision for the pharmacist's role within the precision medicine space will also be discussed. Participants attending will gain insight to begin leading precision medicine implementation efforts at their institutions.

Jill Bates, PharmD MS BCOP FASHP

2:10–3:10 pm

Roundtable (0.1 CEU)

UAN 0465-0000-19-083-L04-P Live only

Roundtable: Operations

USP 797/800
Technology Innovations - APPS
Oral Chemo

3:30–4:45 pm

General Session(1.25 CEU)

UAN 0465-0000-19-084-L04-P Included in virtual meeting

Practice Management Pearls

8 Minute Sessions with 4 Minutes Q&A

Pharmacist City Wide Oncology Journal Club: 17 Years in the Making
Rebecca Fahrenbruch, PharmD BCOP

Establishing an Antineoplastic Surveillance Program in Preparation for USP Chapter <800>
Emily Schroeder, BA CPhT

Development of a Beacon Competency Assessment Tool for Oncology Pharmacists
Janinah Barreto, PharmD MS

Implementation of Chemotherapy Toxicity Risk Scores in Ambulatory Oncology
Shannon Hough, PharmD

Don’t Worry, Be ‘Appy’: Piloting Digiceuticals with Oral Anticancer Therapy
Carolyn Oxencis, PharmD BCOP BCPS

Optimizing Specialty Pharmacy Capture Using Ambulatory Oncology Specialists
David Hughes, PharmD BCOP

4:55–5:25 pm

General Session (0.05 CEU)

UAN 0465-0000-19-085-L04-P Included in virtual meeting

Managing Health System Changes: How Consultants Can Help with Transition

Consultants are routinely engaged by health system and pharmacy leadership to implement strategic initiatives, improve efficiency, or transition teams through other changes. Consultant investments can be shaped through appropriate focus by the team being evaluated. Assessments can come from either internal or external consultant teams with variations in approach and goals. Significant assessments like consultant engagements can be defining moments for departments but can be sources of fear and concern from staff, with a source of resistance to change. Effective leadership through candid communication and team alignment will help departments survive transitional change. This presentation will provide one community cancer program’s experience with an internal consultant assessment and eventual adaption to corporate standards after an acquisition.

Kathryn Wheeler, PharmD BCOP BCPS

4:55–5:25 pm

General Session (0.05 CEU)

UAN 0465-0000-19-086-L04-P Live only

Meet the Speakers of Practice Management Pearls

Rebecca Fahrenbruch, PharmD BCOP

Emily Schroeder, BA CPhT

Janinah Barreto, PharmD MS

Shannon Hough, PharmD

Carolyn Oxencis, PharmD BCOP BCPS

David Hughes, PharmD BCOP

5:35–6:05 pm

General Session (0.05 CEU)

UAN 0465-0000-19-087-L04-P Included in Virtual Meeting

HOPA Voices- An Inadvertent Path to Leadership: “Investigating” Passion, Gaining Perspective and Becoming a Compassionate Leader

In this session, Dr. Finnes will discuss her non-traditional path to becoming a pharmacy leader. She will touch on how her melanoma diagnosis in 2008 and metastatic disease diagnosis in 2014 helped her gain perspective both personally and professionally. Dr. Finnes’ passion for scholarship and finding advancements in cancer care led her to a career in cancer research and investigational drugs.

During her journey as both a hematology oncology pharmacist and cancer patient, Dr. Finnes was involved in committee work for several organizations. Through this experience, she developed her leadership skills and learned about different styles of leadership. She will discuss various types of leadership including democratic, strategic, transformational, and servant leadership, while outlining the effectiveness of each type depending on the environment. Dr. Finnes states, “As a leader and manager, one must adjust leadership styles for different types of personnel and goals. One must also practice reflective listening. Most importantly, as a leader, one must empower others to spread their ideas and passion.”

Heidi Finnes, PharmD BCOP

Saturday, September 14, 2019

8–9 am

General Session (0.1 CEU)

UAN 0465-0000-19-088-L04-P Included in Virtual Meeting

Jumping Hurdles, Breaking Down the Wall: Strategies to Overcome Site of Care Restrictions

At UW Health, medication prior authorization services are internal to the pharmacy department. Heather works closely with the PA team to ensure patients needing pharmacy or medical benefit review for chemotherapy and supportive care medications are approved. One challenge that continues to be encountered are site of care restrictions. Since more commercial payors are mandating site of coverage restrictions, an algorithm for how to triage these patients and maintain care at UW Health was developed. While this workflow primarily applies to non-oncology patients, it has (and can) be adopted for oncology patients.

The purpose of this session will be to review this algorithm as well as discuss other strategies (e.g. contract negotiations, provider/patient attests) that can be used to help prevent SOC restrictions from occurring.

Heather Jones, PharmD MS

8–10 am

Roundtable (0.1 CEU)

UAN 0465-0000-19-089-L04-P Live only

Roundtable: Investigational Drug Services

Residency Start Up
Billing Fee Structure
Position Justification
"Have To"
Centralized Model
Onc vs Non Onc Services

9–10 am

General Session (0.1 CEU)

UAN 0465-0000-19-090-L04-PIncluded in virtual meeting

Value Based Care

Session description coming soon.

Burt Zweigenhaft, BS

Regulatory Updates

HOPA's Washington, DC representative will discuss current regulatory issues that may impact hematology/oncology pharmacists and their patients.

Learning Objectives:

  • Identify and discuss the Trump Administration, and subsequent federal agencies, proposals for lowering out-of-pocket costs for patients.
  • Describe HOPA's health policy activities in relation to lowering out-of-pocket costs for patients.
  • Discuss opportunities to support HOPA's regulatory agenda.

Jeremy Scott, MA

10:30 am–12 pm

General Session (0.15 CEU)

UAN 0465-0000-19-091-L04-P Included in virtual meeting

Generational Differences

By the end of this session attendees will be able to:

  • Provide overview of generations in the workforce including leading change across the generational differences
  • Outline how your generational group would approach and manage the scenario

10:30 am–12 pm

Roundtable (0.1 CEU)

UAN 0465-0000-19-092-L04-P Live only

Roundtable: Financial

Cost Saving Initiatives
Financial Impact of CarT
Optimizing Reimbursement
Reducing Financial Toxicity

1–2 pm

General Session (0.1 CEU)

UAN 0465-0000-19-093-L04-P Included in virtual meeting

Battle Burnout Through Resilience

Rates of burnout among pharmacists are similar to that of other health care providers. More alarming perhaps is that pharmacy ranks among the top professions with the highest rates of suicide. Newer research suggests these trends may start within pharmacy residency training programs and then continue into the pressures of professional practice. If left unabated, this chronic stress can lead to an array of psychological distress ranging from burnout to anxiety, depression, substance misuse/abuse, and increased suicide risk. This talk will examine these findings and introduce the concept of resilience as a means of adapting to the chronic stress inherent in professional pharmacy practice. Key strategies for developing resilience, as well as effective psychological coping to manage stress and promote wellness, will be discussed as a means to reduce burnout and the risk of more serious psychopathology.

Jason Bonner, PhD

2–3 pm

Keynote Address(0.0 CEU)

Included in virtual meeting

Dr. Steven Eisenberg